No tax




Security policy (edit with Customer reassurance module)


Delivery policy (edit with Customer reassurance module)


Return policy (edit with Customer reassurance module)

Combined antiseptic preparation with anti-inflammatory effect for local use in the oral cavity and pharynx. It has an antimicrobial effect. Active against a wide range of gram-positive and gram-negative microorganisms.
Indications for use
- infectious and inflammatory diseases of the oral cavity and pharynx
Dosage and administration
Adults: 1 pastilka every 2 hours. The maximum daily dose of 8 lozenges.
Pastilles are resolved to complete dissolution.
Side effects
- allergic reactions
- hypersensitivity to the drug components
- children's age up to 18 years
Drug interactions
Clinically significant interaction of Adzhisept® drug with drugs of other groups was not revealed.
special instructions
When taking the drug in patients with diabetes, it is necessary to take into account that each pastille contains 1.56 mg of sugar.
Pregnancy and lactation
The use of Ajisepta® during pregnancy and lactation is possible after evaluating the benefit / risk ratio for both the mother and the fetus or child.
Features of the effect of the drug on the ability to drive a vehicle or potentially dangerous machinery
Ajisept® does not affect the ability to drive vehicles and other mechanisms.
Due to low systemic absorption, overdose is unlikely.
Symptoms: discomfort in the gastrointestinal tract.
Treatment: symptomatic therapy.
Release form and packaging
6 lozenges in a contoured cell-free aluminum foil packaging.
4 planimetric packages with instructions for medical use in a pack of cardboard.
Storage conditions
Store in a dry, dark place at a temperature not exceeding 30 ° C.
Keep out of the reach of children!

48 Items